DEC 23, 2015 8:02 AM PST

Immune Cell Regulation to Treat Prostate Cancer

WRITTEN BY: Kara Marker
Inhibiting large cellular populations of myeloid derived suppressor cells (MDSCs) could be a new therapy for prostate cancer, results show from a study at the University of Texas MD Anderson Cancer Center.

Upon infection by a pathogen or cancerous cells, MDSCs expand and suppress the T cell response needed by the body to properly fight cancer growth. Reversing this process might be the key to treating prostate cancer.
 

"MDSCs are infiltrating immune cells that promote tumors through their striking lack of immunological response,” said Y. Alan Wang, PhD and co-author of the study paper recently published in Cancer Discovery.

At first glance it seems that the T cell-inhibiting action of MDSCs is counterintuitive, but this action does come in handy when the body is regulating “immune response and tissue repair” in healthy individuals (Nature Reviews Immunology).

Using a unique prostate cancer mouse model and patient tumor samples, scientists from the University of Texas depleted MDSCs in the models and observed the subsequent response of the tumors. After seeing progression suppressed, the team was also able to identify a regulatory pathway involving Hippo-Yap1 and Cxcl5, a chemokine that attracts MDSCs which then express anther protein, Cxcr2. Because of its association with MDSCs, blocking Cxcr2 similarly suppressed tumor progression to when MDSCs are directly suppressed.

The same result also occurred when Yap1 expression was inhibited. As a regulator of Cxcl5, Yap1 is unable to recruit MDSCs to the tumor site when inhibited.

"The targeting of either MDSC recruitment or infiltrated MDSCs may represent a valid therapeutic opportunity in treating advanced prostate cancer." Said Ronald A. DePinho, MD, and the other co-author on the paper.

Watch the following video to learn more about prostate cancer.

Source: University of Texas MD Cancer Center 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 04, 2019
Immunology
AUG 04, 2019
New Research In Reversing Deafness
Hair cells inside the human ear are responsible for sensing and relaying sound to the brain.  In all mammals except humans, these cells can regenerate...
SEP 16, 2019
Cell & Molecular Biology
SEP 16, 2019
Stem Cell Derived Natural Killer T Cells as Novel and Long-term Cancer Treatment
Hematopoietic stem cells are used to create a population of Natural Killer T-cells that could sustain and renew within the immune system, and attack cancer cells....
OCT 19, 2019
Neuroscience
OCT 19, 2019
Autism May be Linked to an Immune Disorder
Until now, diagnosis for autism spectrum disorder have relied on behavioral assessments looking for symptoms including poor social and communication skills...
FEB 01, 2020
Cell & Molecular Biology
FEB 01, 2020
Immunity in the Gut Ramps Up Around Mealtimes
Scientists have found that our immune system benefits when we eat regular meals....
FEB 10, 2020
Immunology
FEB 10, 2020
Measles infections can give the immune system amnesia
The immune system detects the presence of invading microbes that it recognizes from previous infections, and initiates a full-blown immune response. New re...
FEB 19, 2020
Immunology
FEB 19, 2020
Rainbow trout hold the key to unravelling immunological mysteries
What do the gut microbiome, antibodies, and rainbow trout have in common? A lot, says researcher J. Oriol Sunyer from the University of Pennsylvania’...
Loading Comments...